Share

World's leading clinical conference on bone, joint and muscle health

Programme

Go to Sponsored Sessions

Sunday May 7th - CEST Time zone

08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 130
Psoriatic disease. New therapeutic horizons and the effect on the musculoskeletal system in the era of COVID-19 Chairperson : Athanassiou Panagiotis
  • Psoriatic disease in the era of COVID-19 Athanassiou Lambros
  • Psoriatic disease. Comorbidities Pavlos Tsakiridis
  • Psoriatic disease and rehabilitation Yannis Dionyssiotis
  • Psoriatic disease. New therapeutic horizons. Small molecule inhibitors, biologic agents and JAK inhibitors Athanassiou Panagiotis
08:00
Room 129
Tobacco harm reduction and bone health Chairpersons : Maria Luisa Brandi & Umberto Tarantino
  • Cigarette smoke and bone disorders Chiara Greggi
  • Health lifestyles and bone health: the Case of Tobacco Harm Reduction Riccardo Polosa
  • Role of cigarette smoke and tobacco heated products on bone remodeling Giovanni Li Volti
08:00
Room 123
Fracture Liaison Service: From Zero to Hero – National experience Chairpersons : Yasser El Miedany & Mathias Toth
  • Closing the treatment gap Naglaa Gadallah
  • How pharmaceutical industry can support national FLS Yasser El Miedany
  • Falls: raising awareness through HCP education Susan Plummer
08:00
Room 121
Evidence based Latin American guidelines about prevention, diagnosis and treatment of glucocorticoid induced osteoporosis. An update Chairpersons : Osvaldo Daniel Messina & Claudia Campusano
  • Guidelines methodology Patricia Clark
  • Results Jorge A Morales Torres
  • Panel proposal for pharmacological therapies according to fracture risk stratification Osvaldo Daniel Messina
08:00
Room 119
Osteoimmunology in the era of COVID-19 Chairperson : Kostoglou-Athanassiou Ifigenia
  • Pandemics through the ages. The role of stress trauma and frailty Yannis Athanassiou
  • Menopause and osteoimmunology Yannis Dionyssiotis
  • Osteoimmunology and current treatment of osteoporosis Athanassiou Panagiotis
  • Osteoimmunology. The connection between bone and the immune system Kostoglou-Athanassiou Ifigenia
08:00
Room 120
The Current and Future Approaches in the Diagnosis and Management of Sarcopenia Chairpersons : Pınar Borman & Belgin Karaoglan
  • What is sarcopenia? How is it diagnosed? Burcu Duyur Çakit
  • Sarcopenia and New Biomarkers. Aylin Sepici Dinçel
  • The Management of Sarcopenia Pınar Borman
08:00
Room 122
Update in Musculoskeletal Conditions with Hand involvement Chairpersons : Fitnat Dincer & Andreas Winkelmann
  • Degenerative joint disease of Hand, Osteoarthritic Hand Fitnat Dincer
  • Hand involvement in Complex Regional Pain Syndrome-CRPS (Sudeck atrophy, osteoporosis in hand) Raquel Valero Alcaide
  • Soft tissue lesions / non articular involvement of Hand Andreas Winkelmann
08:00 - 09:00
Room 131-132
ESCEO SYMPOSIUM Update on the role of oral Bisphosphonates in the treatment of osteoporosis Chairpersons : Jean-Marc Kaufman & René Rizzoli
  • Risk/benefit ratio of oral Bisphosphonates in the treatment of osteoporosis (fracture reduction, GI, CV, AFF, ONJ,…) Nicholas Harvey
  • New formulation of oral Bisphosphonates: Impact on the reduction of osteoporosis treatment gap Nick Fuggle
  • Discussion Friederike Thomasius
08:00 - 09:00
Room 118
SICOT-ESCEO-IOF Symposium Standards in Management of Osteoporotic Fractures Chairperson : Ilir Hasani
  • Management of Osteoporotic Spinal Fractures Ilir Hasani
  • Treatment of unstable osteoporotic bimalleolar ankle fractures Karhao Teoh
  • Management of Acetabular fractures in elderly Eftychios Bolierakis
  • Proximal femur fractures in elderly Mario Staresinic
09:00 - 10:00
Meet-The-Expert Session
09:00
Room 122
Complex cases – questions and answers Elaine Dennison
09:00
Room 123
High bone mass: what should we do? Celia Gregson
09:00
Room 119
Transgender medicine and bone Jean-Marc Kaufman
09:00
Room 120
Dietary patterns and bone health Nicola Veronese
09:00 - 10:00
Poster Area
Poster Viewing Session III
09:00 - 10:00
Room 130
Educational Lecture organized by OAFI The beneficial effects of pharmaceutical-grade chondroitin sulfate on cardiovascular system in patients with osteoarthritis Francisco J. de Abajo
09:00 - 10:00
Room 118
Sponsored Meet-The-Expert Session

* See details on the Sponsored Satellite Symposia page

10:00 - 12:00
Auditorium A
Scientific Session VII Chairpersons : Adolfo Diez-Perez & Radmila Matijevic
10:00
Auditorium A
Plenary Lecture 9 Do high and very high fracture risk really matter? Kassim Javaid
Have a sneak peek
10:30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards Nicholas Harvey & René Rizzoli
10:40
Auditorium A
Oral communication selected from abstracts OC34: LONG-TERM SAFETY OF BUROSUMAB IN ADULTS WITH X-LINKED HYPOPHOSPHATAEMIA (XLH) IN A PHASE 3B OPEN-LABEL STUDY Presenting author: M. K. Javaid Authors: P. Kamenicky, C. Roux, R. Lachman, M. L. Brandi, M. Cohen-Solal, R. Crowley, S. Ralston, R. Keen, J. Bowler, L. Henderson, W. Sun, A. Tudor and E. Quattrocchi
10:50
Auditorium A
Oral communication selected from abstracts OC35: HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH TUMOR-INDUCED OSTEOMALACIA: REVIEW OF PATIENT HISTORIES PRIOR TO ENTRY IN CLINICAL TRIAL UX023T-CL201 Presenting author: B. Johnson Authors: S. M. Jan de Beur, T. O. Carpenter, K. Dahir, E. A. Imel, M. B. Zanchetta, A. Williams, Z. Li and M. Sharp
11:00
Auditorium A
Oral communication selected from abstracts OC36: A DIETARY PLUS EXERCISE INTERVENTION IMPROVES BONE TURNOVER IN PATIENTS WITH METABOLIC SYNDROME AND TYPE 2 DIABETES Presenting author: M. Gerbaix Authors: D. Courteix, G. Lac, B. Lesourd, R. Chapier, A. Vinet, G. Walther, P. Obert, F. Dutheil and S. L. Ferrari
11:10
Auditorium A
Oral communication selected from abstracts OC37: INTEGRATED LONG-TERM BONE MINERAL DENSITY OUTCOMES IN WOMEN RECEIVING RELUGOLIX COMBINATION THERAPY IN LIBERTY AND SPIRIT STUDIES VS NON-TREATED WOMEN Presenting author: M. R. McClung Authors: A. Al-Hendy, N. Johnson, S. R. Cummings, S. L. Ferrari, A. C. Santora, J. C. Arjona Ferreira, R. B. Wagman and Y. Li
11:20
Auditorium A
Oral communication selected from abstracts OC38: ZOLEDRONATE AS A PREVENTATIVE MEASURE FOR BONE LOSS FOLLOWING DENOSUMAB DISCONTINUATION: RESULTS FROM A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL Presenting author: S.-H. Fu Authors: C.-C. Lee, C.-C. Hung, C.-Y. Li and C.-Y. Wang
11:30
Auditorium A
Plenary Lecture 10 Management of premenopausal osteoporosis Peyman Hadji
Have a sneak peek
12:00 - 13:00
Non-Sponsored Symposia
12:00
Room 122
Perioperative bone optimization in the arthroplasty candidate Chairperson : Roberto Enrique Lopez Cervantes
  • State of the art. What do we know about bone density after arthroplasty? Iñigo Etxebarria Foronda
  • The Effect of Antiresorptive on Bone Loss After Arthroplasty. Literature Review and Meta-Analysis of Randomized Controlled Trials Francisco Torres Naranjo
  • Periprosthetic BMD loss and its implication in the revision and complication rates Francisco Linares Restrepo
  • Statement position proposal of how to do "bone optimization in the arthroplasty candidate" Roberto Enrique Lopez Cervantes
12:00
Room 123
Link between diabetes, osteoporosis and bone health - rheumatologist, endocrinologist and registered dietitian point of view Chairperson : Mislav Radić
  • Osteoporosis and bone health in diabetes mellitus Josipa Radić
  • Nutrition and bone health in diabetes-induced osteoporosis Dora Bučan Nenadić
  • Bone health and osteoporosis treatment in diabetes mellitus Mislav Radić
12:00
Room 120
Bone health and cancer: A dicey duo Chairpersons : Yasser El Miedany & Naglaa Gadallah
  • Addressing Bone Loss in Cancer patients: A step forward Walaa Elwakil
  • What Treating Doctors and Breast Cancer Survivors Need to Know About Osteoporosis Mervat Eissa
  • Optimal bone health management strategies in patients with prostate cancer Mathias Toth
  • Bone health in childhood cancer Waleed Hassan
12:00
Room 130
Prevention of osteoporotic fractures: the role of exercise and of FRID (falls risk increasing drugs) avoidance Chairperson : Ana Paula Barbosa
  • The role of post-fracture exercise in women´s physical function and quality of life Anabela Barcelos
  • The role of FRID (Falls Risk Increasing Drugs) avoidance Anabela Pereira
  • Q&A All
12:00
Room 129
Sarcopenia and rheumatoid arthritis Chairpersons : Kostoglou-Athanassiou Ifigenia & Yannis Dionyssiotis
  • Rheumatoid arthritis and muscular involvement Athanassiou Panagiotis
  • Sarcopenia and rheumatoid arthritis Yannis Dionyssiotis
  • Treatment of sarcopenia in rheumatoid arthritis Kostoglou-Athanassiou Ifigenia
12:00
Room 119
Musculoskeletal Functional Capacity in Sub-Saharan Africa Chairperson : Ayse Zengin
  • Co-morbidities of muscle function in older adults from The Gambia Ayse Zengin
  • Impact of HIV on midlife musculoskeletal health in sub-Saharan Africa Celia Gregson
  • Markers of low muscle mass and function: insights from proteomics in middle-aged South Africans Lise Micklesfield
  • Muscle and functional ability in sub-Saharan Africa: The MUFASSA study Kate Ward
12:00
Room 121
Rare Bone Diseases: A view from LATAM Chairperson : Alejandro Román-González
  • Welcome and general overview of rare bone diseases in Latin America Alejandro Román-González
  • X-LINKED hypophosphatemia (XLH): Diagnosis and treatment in adults Adriana Medina
  • Transition of care: From childhood to adulthood. How can we improve the care of our patients with endocrine disorders? Sofia Kastelic
  • Tumor-induced osteomalacia and fibrodysplasia ossificans progressiva in Colombia and Latin America Alejandro Román-González
  • Questions and wrap-up All